Blood Urea Nitrogen as a Predictor of In-Hospital Mortality  in Acute Coronary Syndrome Patients by Wasyanto, Trisulo & Tridamayanti, Annisa
Wasyanto et al./ Blood urea nitrogen as a predictor of in-hospital mortality 
e-ISSN: 2549-0265  241 
Blood Urea Nitrogen as a Predictor of In-Hospital Mortality  
in Acute Coronary Syndrome Patients  
 
Trisulo Wasyanto1,2), Annisa Tridamayanti1,2) 
 
1)Department of Cardiology and Vascular Medicine, Faculty of Medicine, 
Universitas Sebelas Maret 




Background: Acute coronary syndrome (ACS) is one of the major causes of morbidity and 
mortality worldwide. Thus, it is important to effectively diagnose and determine the prognosis and 
mortality risk. While criteria such as Thrombolysis in Myocardial Infarction (TIMI) and Global 
Registry of Acute Coronary Events (GRACE) score are clinically used to work out the prognosis of 
patients with ACS, the examination of Blood Urea Nitrogen (BUN) and creatinine alongside in 
predicting outcome may prove favorable as well. This study aimed to determine the efficacy of BUN 
and creatinine in mortality risk assessment of patients with ACS, and to find which one is better. 
Subjects and Method: This was an analytical study with a cohort retrospective design included 
1463 ACS patients in Dr. Moewardi hospital from January 2014 to July 2018. The relationship 
between admission BUN, creatinine level, and in-hospital mortality were analyzed with chi-square 
and logistic regression. Receiver Operating Characteristic (ROC) curve to determine which one 
better as a predictor of in-hospital mortality. 
Results: The mean age of patients was 60 years old (mean= 60.08; SD= 11.04), which 72.9% were 
men. From all sample, 232 (15.9%) patients were died. In binary log regression models, elevated 
BUN (>50 mg/dL) at admission was an independent predictor of in-hospital mortality (OR= 4.01; 
95% CI= 1.0 to 7.0; p= 0.001). Similar results were obtained for elevated creatinine (>1.3 mg/dL) 
at admission (OR= 3.6; 95% CI= 2.2 to 5.8; p= 0.031). ROC curves showed that area under the 
curve (AUC) of BUN (0.87) was higher than AUC of creatinine (0.61). 
Conclusion: Elevated BUN and creatinine are independent predictors of in-hospital mortality in 
ACS patients. A high level BUN at admission is a more accurate predictor of in-hospital mortality 
than creatinine. 
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BACKGROUND 
Acute Coronary Syndrome (ACS) is a 
leading cause of hospitalization and death 
in the majority of countries, especially in 
developing countries (Go AS et al,. 2013). 
The prevalence and incidence of ACS is also 
very high in Indonesians. The JAC (Jakarta 
Acute Coronary Syndrome) registry study 
concluded that nearly 11% of the population 
in Jakarta had ACS, with 4% of them being 
ST Elevation Myocardial Infarction 
(STEMI) (Dharma et al., 2016).The profile 
of patients with ACS is quite varied, so risk 
stratification is important to provide opti-
mal care in choosing an intervention or 
medically treatment. Several models of risk 
stratification have been developed for ACS 
patients, several of them are Global Regis-
try of Acute Coronary Events (GRACE), 
Thrombolysis in Myocardial Infarction 
(TIMI), and HEART score. This stratifi-
cation can be done when the patient first 
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admitted to hospital. These models consist 
of important prognostic factors, including 
age, gender, angina, risk factors for coro-
nary artery disease (CAD), signs of heart 
failure, systolic blood pressure, heart rate, 
cardiac arrest during admission, ST seg-
ment changes, cardiac enzymes, and serum 
creatinine. Increased serum creatinine 
levels, which are commonly used as mark-
ers of kidney function, are also known as 
predictors of ACS outcome. According to 
Granger and friends, creatinine increase of 
1.0 mg/dL is increasing the risk of death in 
ACS patients by 15-35% (Granger et al., 
2003).  
Creatinine as a marker of kidney 
function is predictors for worse outcomes 
in ACS patients (Shiraishi et al., 2016). 
Estimation of Glomerulus Filtration Rate 
(GFR), which is calculated by serum crea-
tinine, is also a marker of kidney function. 
A reduction in the estimated GFR has also 
been reported as a predictor for poor 
prognosis in ACS patients (Lee et al., 2016). 
However, kidney function based on serum 
creatinine levels may not perfectly reflect 
the actual GFR, because serum creatinine 
levels are influenced by several factors, 
such as age, sex, muscle mass, and diet 
(Kimura et al., 2016). Blood Urea Nitrogen 
(BUN) is a marker of other kidney func-
tions. The urea concentration is determined 
by the balance of excretion and reabsorp-
tion in the kidney. Urea reabsorption is 
closely related to water reabsorption in the 
distal nephron which is under the influence 
of antidiuretic hormones whose excretion is 
affected by angiotensin II (Aronson et al., 
2004). In addition to low GFR conditions, 
increased urea levels are associated with 
activation of the renin-angiotensin-aldos-
terone system and sympathetic nerves, 
which may be caused by renal hypo-
perfusion from hypovolemia, renovascular 
disease, and decreased cardiac output 
(Kazory et al., 2010). Therefore, urea can be 
a marker that reflects disorders of cardio 
renal function and neurohormonal active-
tion. In patients with heart failure, high 
urea levels are a marker of strong mortality 
compared to creatinine (Chen et al., 2012). 
This relationship has also been shown in 
patients with ACS (Gibson et al., 2003). 
In developing country populations, 
especially Indonesia, the relationship 
between BUN and mortality in ACS pati-
ents has not been widely described by 
researchers. There is a possibility that BUN 
is a better predictor of mortality compared 
to creatinine, seeing that several studies in 
developing countries have proven its 
significance (Grundy et al., 2018). 
 
SUBJECTS AND METHOD 
This study was an analytical study with a 
cohort retrospective design to determine 
the relationship between BUN and creati-
nine with hospital mortality. Patient sample 
data and results of laboratory tests was 
taken from the medical records installation 
of Dr. Moewardi Hospital from January 
2014 to July 2018 that were diagnosed with 
STEMI, Non ST Elevation Myocardial 
Infarction (NSTEMI) and Unstable Angina 
Pectoris (UAP) based on clinical, electro-
cardiographic features and laboratory exa-
minations. Exclusion criteria are patients 
with incomplete data, history of chronic 
kidney disease and hemodialysis. The inde-
pendent variables for cohort analysis in this 
study were age, gender, risk factors (dia-
betes mellitus, hypertension, previous coro-
nary heart disease and smoking), hemo-
globin, leukocytes, platelets, urea, creatini-
ne, sodium, potassium, chloride, and glu-
cose. The dependent variable in this study 
was mortality during hospitalization. 
Acute myocardial infarction according 
to European Society of Cardiology (ESC) in 
Fourth Universal Definition of Myocardial 
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Infarction (Thygesen et al., 2019) is defined 
as detection of an increase and/or decrease 
in cardiac biomarkers with at least 1 value 
above the 99th percentile of the upper 
reference limit, together with evidence of 
myocardial ischemia with at least one of the 
following: symptoms of ischemia, changes 
in electrocardiography (ECG) that indicate 
new ischemia and evolution of pathological 
Q waves on the ECG, and imaging evidence 
decreases new myocardial viability or ab-
normal segmental motion of the myocardial 
wall. Hypertension is defined as an increase 
in systolic blood pressure >140mmHg and 
diastolic >90 at least two measurements 
with or without the use of antihypertensive 
drugs (Grundy et al., 2018). Diabetes 
mellitus (DM) is defined if fasting blood 
sugar >126 mg / dL, 2 hours post prandial 
>200 mg / dL, HbA1C >6.5, and with or 
without the use of antidiabetic drugs (Ame-
rican Diabetes Association, 2004). Smoking 
is defined as a history of smoking within 10 
years. Dyslipidemia is stated when LDL 
>100 mg/dL (Catapano et al., 2016). In-
hospital mortality is stated as a death that 
occurs during hospitalization. 
Continuous data are presented as 
mean ± SD if distributed normally, while 
distributed abnormally are presented as 
median (min-max). Categorical variables 
are expressed as a percentage (%). The 
baseline characteristics of patients in the 
study group were compared by indepen-
dent sample t-test for continous distributed 
normally variables, and Mann-Whitney for 
continuous variable that was abnormally 
distributed. For categorical variables we 
analyzed with X2. The relationship BUN 
and creatinine with hospital mortality was 
analyzed with bivariate Ӽ2 test. Based on 
bivariate analysis, variables related to hos-
pital mortality with p<0.05 were included 
in multivariate analysis using logistic 
regression analysis. Receiver Operating 
Characteristic (ROC) was used to see the 
level of specificity and sensitivity of urea 
and creatinine and determine between the 
two which were better as predictors of 
hospital mortality. The results of the study 
were expressed as p values, Area Under 
Curve (AUC), Odd Ratio (OR) and 95% 




Clinical Characteristic of ACS 
Patients 
A total of 1680 patients with Acute Coro-
nary Syndrome (ACS) were included in this 
study. Of these patients, 38 patients were 
excluded because had history of Chronic 
Kidney Disease (CKD) or history of hemo-
dialysis, 217 patients were excluded because 
of incomplete data. We analyzed a total of 
1425 samples of patients with ACS, 1062 
(73.9%) of whom were male and 363 
(26.1%) were women. The average age in 
the subjects of this study was 60.08 ± 11.04 
years, with the youngest age was 23 years, 
and the oldest age was 97 years. Of the total 
ACS events, 909 (62.1%) cases were 
STEMI, 296 (20.4%) cases were NSTEMI, 
and 256 (17.5%) were UAP  
In the sample population of men who 
experienced ACS, 65.7% were diagnosed 
with STEMI, while in the female group, 
fewer were diagnosed with STEMI than 
men, namely 55.6%, the rest were diag-
nosed as NSTEMI (22.3%) and UAP 
(22.1%). Patients with complications of 
heart failure are characterized by Killip 
classification. In this study, there were 1026 
patients (72.7%) with Killip I, and 399 
patients (27.3%) Killip ≥ II, of which 74.4% 
of patients with Killip ≥ II were STEMI 
patients (Table 1). 
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Table 1. Risk Factor of patients in relation to type of ACS 
 Acute Coronary Syndrome 
Total STEMI NSTEMI UAP 
Gender Male 1062 (73.9%) 711 (65.7%) 209 (19.3%) 162 (14.9%) 
Female 363 (26.1%) 212 (55.6%) 85 (22.3%) 84 (22.1%) 
Killip Killip I 1026 (72.7%) 626 (58.8%) 210 (19.7%) 228 (21.4%) 
Killip ≥ II 399 (27.3%) 297 (74.4%) 84 (21.1%) 18 (4.5%) 
Hypertension Yes 725 (50.9%) 441 (59.1%) 166 (22.3%) 139 (18.6%) 
No 699 (49.1%) 482 (67.2%) 128 (17.8%) 107 (14.9%) 
Diabetes 
Mellitus 
Yes 383 (26.9%) 255 (64.5%) 75 (18.9%) 65 (16.6%) 
No 1042 (73.1%) 668 (62.5%) 219 (20.5%) 181 (17.0%) 
History of 
CAD 
Yes 171 (12.1%) 61 (34.2%) 60 (33.7%) 57 (32.1%) 
No 1254 (87.9%) 861 (67.0%) 234 (18.2%) 189 (14.7%) 
Smoking Yes 845 (59.3%) 581 (67.1%) 156 (17.9%) 130 (15.0%) 
No 580 (40.7%) 342 (57.4%) 138 (23.1%) 116 (19.4%) 
Dyslipidemia Yes 299 (21.3%) 161 (52.1%) 102 (32.8%) 48 (15.1%) 
No 1126 (78.7%) 762 (60.9%) 192 (19.3%) 198 (19.8%) 
 
The most prevalent cardiovascular 
disease risk factors for patients with ACS in 
Dr. Moewardi hospital is smoking. More 
than half of ACS patients (59.3%) were 
smokers with a duration of more than 10 
years. Hypertension is the second most 
prevalent risk factor after smoking (50.9%) 
(Table 1). 497 (34%) patients had 3 or more 
risk factors. 761 (52%) patients had 2 risk 
factors, and the rest (14%) only had 1 risk 
factor. 
Of the total patients, 1197 patients 
(84.1%) lived during hospitalization, and 
228 (15.9%) patients died in the hospital. 
The causes of hospital mortality in ACS 
patients include cardiogenic shock (59.9%), 
ventricular arrhythmias (25%), respiratory 
failure (6.8%) and septic shock (5.6%) 
(Figure 1). Annual mortality rates from 
2014 to 2018 was decreased, from 20.7%, 
then 20.5%, 14.9% to the last 11.8% in 2018 
(Figure 2). This showed an increase of 
survival in ACS patients at Dr. Moewardi 
hospital from 2014 to 2018. 
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Figure 2. Hospital Mortality Rate for ACS patients 
from January 2014 to July 2018 
 
Table 2. Sample characteristics  
Variable All Samples  In-Hospital Mortality p 
Survived  Dead 
Age (years) 60,00 (23-100) 59,46 (23-92) 63,39 (32-100) 0.001 
Men (%) 1081 (73.9%) 925 (85.5%) 156 (14.4%) 0.110 
Diabetes Mellitus 395 (26.9%) 82 (20.7%) 313 (79.2%) 0.001 
Hypertension 746 (50.9%) 637 (85.3%) 109 (14.6%) 0.179 
History of CAD  178 (12.1%) 20 (11.2%) 158 (88.7%) 0.040 
Smoking 866 (59.3%) 737 (85.1%) 129 (14.8%) 0.215 
Dyslipidemia 311 (21.3%) 159 (51.1%) 152 (48.9%) 0.132 
Type of ACS     
   STEMI 922 (63.0%) 745 (80.8%) 177 (19.2%) 
   NSTEMI 294 (20.8%) 148 (84.4%) 46 (15.6%) 
   UAP 237 (16.2%) 237 (96.3%) 9 (3.7%) 
Killip ≥ II 399 (27.3%) 157 (39.3%) 242 (60.6%) 0.001 
Hemoglobin 13.07 ± 1.89 13.17 ± 1.79 12.58 ± 2.28 0.066* 
Leukocyte 11.62 ± 4.37 11.14 ± 4.07 14.11 ± 4.96 0.021* 
Thrombocyte 236.00 (33-784) 241.44 (33-652) 250.49 (124-784) 0.309** 
BUN 32 (13-253) 35 (13-57) 60 (47-253) 0.001** 
Creatinine 1.10 (0.72-6.91) 1.18 (0.72-2.31) 1.62 (1.12-6.91) 0.001** 
Natrium 135 ± 4.68 135 ± 4.50 134 ±5.33 0.099* 
Kalium 3.9 ± 0.68 3.9 ± 0.67 4.1 ± 0.73 0.106* 
Chloride 104 ± 5.38 104 ± 5.40 103 ± 5.25 0.266* 
Glucose 137 (45-681) 161 (56-681) 221 (45-551) 0.001** 
 
Table 2 illustrates the relationship 
between clinical profile and biochemical 
characteristics of patients with in-hospital 
mortality. Patients with old age and pati-
ents with Killip II presentation had a signi-
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(p= 0.001). ACS patients who had a history 
of DM and previous CAD had a tendency to 
dead that were statistically significant (p = 
0.002 and p = 0.042). ACS patients with 
co-existent cardiovascular risk factor as 
smoking and dyslipidemia did not reveal 
any statistically significant higher mortality 
risk when compared to those without these 
risk factors. 
Relationship between BUN and 
Creatinine with In-hospital Mortality 
From table 2, it can be seen that hospital 
deaths occur more in patients with BUN 
and creatinine levels at the time of initial 
admission (p= 0.001 and p= 0.001).  
Because of BUN and creatinine data 
are not normally distributed, the data are 
analyzed using the Mann-Whitney test. 
Furthermore, we also changed the BUN and 
creatinine data into categorical data, with 
BUN cut-off> 50 mg/dL and creatinine 
>1.3 mg/dL. A value below the cut-off is 
defined as a normal value. The hospital 
mortality risk between normal and high 
values at urea and creatinine levels was 
analyzed by chi-square. Then analyzed by a 
multiple logistic regression (Table 3). 
Table 3. In-hospital Mortality Risk Analysis 
Varia-
bles 




Alive Dead p OR (CI 95%) p OR (CI 95%) p 
BUN (mg/dL)  








> 50 133 197 
Creatinine (mg/dL)  




0.031 4.24 (3.14-5.39) 0.027 
> 1.3 261 101 
* Adjusted with leucocyte, glucose, and Killip classification  
 
From the results of logistic regression 
analysis, high level BUN at the first time of 
admission had 5 times higher (OR = 5.01, 
95% CI 1.00-7.01, p=0.001) risk for dying 
in hospital compared to normal BUN values 
in patients with ACS. Likewise, with crea-
tinine, patients with high creatinine values, 
the risk of death in the hospital was 4 times 
(OR= 3.60; 95% CI= 2.23-5.80) higher 
compared to the normal creatinine value (p 
<0.005). When added with leukocytes and 
glucose variables in the multivariate ana-
lysis with logistic regression, a high level 
BUN > 50 mg / dL had a risk of death 14 
times compared to normal group (OR= 
13.92, 95% CI= 10.09-16.11, p=0.001). 
Increased BUN value has more effect on the 
risk of in-hospital mortality compared to 
creatinine values (OR 13.92 vs OR 4.24). 
On the ROC curve, BUN correlated 
significantly with in-hospital mortality, 
with Area Under Curve (AUC) 87.1% (P 
<0.001, 95% CI 0.842-0.899). Compared 
with creatinine, the AUC value of creatinine 
was lower, which is 61.2% (95% CI= 0.57 to 
0.65; p<0.001) (Figure 3). It can be 
concluded that BUN are more accurate 
than creatinine as predictors of in-hospital 
mortality in patients with ACS. In this curve 
can also obtained the optimum BUN cut-off 
value >50 mg/dL has sensitivity of 84.9% 
and specificity 89.2% as a predictor of 
death, and creatinine value <1.3 mg / dL 
has a sensitivity of 59.5% and specificity of 
71.4%. 
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Figure 3. Comparison of BUN and Creatinine as In-hospital Mortality Predictor 
 
DISCUSSION 
In this study, the majority of patients 
presented at mean age of 60 years, with the 
youngest was 23, and the oldest was 100. A 
finding which is consistent with previously 
published reports on CREATE Registry, 
which report a clear preponderance of male 
subjects, with average age of 57 ± 12.1 
(Xavier et al., 2008). The majority of ACS 
patients in our study were male, similar to 
ACS registry study that conduct around 
Jakarta (JAC Registry), where 85% of ACS 
patients are dominated by men (Dharma et 
al., 2016). In addition, most ACS patients in 
this study were diagnosed with STEMI 
(62%). This finding is similar to CREATE 
registry study (Xavier et al., 2008). In 
contrast, reports from developed countries 
indicate that less than 40% of patients with 
ACS had STEMI (Ranjith et al., 2011), 
suggesting that Asian people are more 
likely to experience extensive myocardial 
infarction and worse prognosis than other 
populations (Ravi et al., 2013). 
The most commonly observed risk 
factors in the current study population 
included smoking, hypertension, and 
diabetes mellitus, while a history of CAD 
and dyslipidemia occurred less frequently. 
Although the findings presented here are 
consistent with those of the European and 
Mediterranean population (Euro Heart 
Survey) (Mandelzweiget al., 2006),smokers 
and patients with a history of hypertension 
in this study have a greater proportion 
compared to the Euro Heart Survey study 
(59% and 51% vs. 18.5% and 39%). Com-
pared with Canadian subjects in the 
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CANRACE registry study, ACS patients in 
this study had a similar prevalence of 
diabetes and hypertension (27% and 51% vs 
26% and 59%), but the prevalence of 
smoking was far more in our study (59% vs 
27%) (Paul, 2010). Apart from the descript-
tive explanation above, our study also 
shows that there is a significant relation-
ship between the increase in BUN and 
creatinine levels with in-hospital mortality 
of ACS patients. BUN and creatinine are 
known as predictor of kidney dysfunction. 
One condition that can worsen the outcome 
of acute coronary syndrome is acute heart 
failure, which can cause acute kidney 
injury. This condition is called type 1 
cardiorenal syndrome (CRS). A number of 
literature shows that patients with CRS 
type 1 are at high risk for poor outcomes 
(Paul, 2010).  
This independent effect may be due 
to the associated acceleration in cardio-
vascular pathobiology due to renal dysfunc-
tion through neurohormonal activation, cell 
signaling, oxidative stress, or fibrosis cas-
cades. Acute kidney injury is an indepen-
dent risk factor for 1-year mortality in 
patients with acute heart failure, including 
patients with an increased STEMI who 
experience signs and symptoms of heart 
failure or have a decreased left ventricular 
ejection fraction (JoAnn et al., 2011).In 
previous studies, to determine the presence 
of renal dysfunction, clinicians used serum 
creatinine, estimated creatinine clearance, 
or glomerular filtration rate (GFR). How-
ever, estimation of renal function based on 
serum creatinine is imperfect and may not 
be sufficient to assess acute changes in 
actual GFR or other aspects of renal func-
tion, especially when GFR is only slightly 
reduced (Kirtane et al., 2005).  
Blood urea nitrogen concentrations 
have been considered as more specific 
markers of kidney function than serum 
creatinine and GFR estimates. In addition, 
an increase in urea is independent, not 
solely due to a decrease in GFR. This is 
because urea reabsorption is a passive 
process associated with sodium and water 
reabsorption due to activation of the 
sympathetic nervous system and Renin 
Angiotensin Aldosterone System (RAAS), 
where the condition better represents the 
kidney response to systemic hypoperfusion 
due to a decrease in cardiac output rather 
than intrinsic renal dysfunction (Hata et al., 
2010). In this context, the urea level at the 
time of initial hospitalization and its 
increase during hospitalization can be a 
simple marker of hemodynamic deteriora-
tion, cardiorenal dysfunction and neuro-
hormonal activation (Horiuchi et al., 2018). 
Unlike creatinine, elevated urea levels 
are associated with adverse outcome prog-
nosis regardless of age, SBP, heart rate, 
Killip class, troponin levels, type B natri-
uretic peptides and ST segment changes in 
patients with acute heart disease such as 
ACS, acute heart failure and post Coronary 
Artery Bypass Graft (CABG) (Cauthen et al., 
2008). According to a study by Cauthen 
and friends, the increased risk of death 
within 1 year after myocardial infarction 
was associated with BUN levels >6.1 mmol/ 
L, and this marker was more important for 
prognosis of MACE than serum creatinine 
or creatinine clearance (Aronson et al., 
2008). Aronson and friends also stated that 
an increase in urea levels was a significant 
predictor of mortality in ACS patients >65 
years. The opinions of some of these 
researchers are consistent with the results 
of our study that high urea levels are inde-
pendent risk factors for hospital mortality 
in ACS patients. The level of BUN can add 
prognosis information to evaluating ACS 
patients at the time of initial inpatient care 
which is very useful for patient 
management 
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This study has several limitations. 
This study is a cohort retrospective, in-
volving all ACS patients from January 2013 
to July 2018 in Dr. Moewardi hospital 
which is a type A referral hospital for heart 
disease in the south region of Central Java. 
So the results of this study are quite 
representative for ACS patients in mid-
urban city of Indonesia. 
Elevated BUN and creatinine are 
independent predictors of in-hospital 
mortality in ACS patients. A high level BUN 
at admission could be a more accurate 
predictor of in-hospital mortality than 
creatinine. Serum BUN may serve a simple 
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